However, for approximately 25% of AML patients, more than 90% of the total AML cell population is CD34- [32,34,35], and this phenotype is associated with the nucleophosmin 1 (NPM1) mutation [33,34]. The gene discussed is CD34; the disease is acute myeloid leukemia.